NASDAQ NMS - GLOBAL MARKET · PEBK
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
Peoples Bancorp of North Carolina Inc

Peoples Bancorp of North Carolina Inc

Banking
$43.57
Card
Relationship Map

Follow $PEBK

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $PEBK by email

Veridion Score

BETALOW CONF · 5 of 6 factors measuredMethodology
Analyst data unavailable at compute time
PEBK
Peoples Bancorp of North Carolina Inc
Mon Sep 21 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

54/ 100
Veridion Score
Middle range · LOW confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5 of 6 factors measured · Mon Sep 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is PEBK moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading PEBK catalysts
About Peoples Bancorp of North Carolina Inc
STATE COMMERCIAL BANKS
Listed since
1985
Employees
276
Country
US

Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$43.57
Last session
Day high
$43.57
Last session
Day low
$43.57
Last session
Previous close
$43.57
52W high
$45.25
-3.71% from high
52W low
$28.20
90% of range
Market cap
$231.9M
P/E
12.89×
EPS
$3.38
Beta
-0.22
Shares out
5.3M
Avg volume
31.7K
VWAP
$43.57
Last session
Price history computed in-house
1W
-3.26%
1M
-1.71%
3M
-0.80%
1Y
+37.62%
YTD
+20.36%
SMA 50 $43.56 · above
SMA 200 $40.34 · above
52W position 90%

PEBK overview

Veridion Score
54
Registered · 2026-09-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around PEBK.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading PEBK Form 4 filings
Public disclosures

Congress activity in PEBK

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for PEBK in the cached public ledger.

Federal contracts

PEBK contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PEBK in this window.
Lobbying spend

PEBK lobbying filings, year to date.

Registered lobbying filings matched to Peoples Bancorp of North Carolina Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PEBK in this window.
Loading news for PEBK
Analyst ratings
Sovereign unlock shows live analyst consensus for PEBK.
Options
Sovereign unlock shows live options positioning for PEBK.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.